Citigroup heads into the new week with some of August's sharpest bearish signals softening at the edges — but the overall posture still leans cautious.
Yesterday's note flagged the put-call ratio hitting a 52-week high of 1.43 on August 31. That level has since pulled back to 1.39 on September 1. The move is modest, but it's the first easing after a sustained climb. The z-score now reads 1.44 — still above the 20-day mean of 1.33, but no longer in statistically rare territory. Options traders remain more defensively positioned than usual; they've just stepped back from the most extreme reading of the past year. Similarly, the short interest spike that drove last week's headline number — shares short jumped from 24.7 million to nearly 30 million on August 24 — held steady through the week rather than building further. At 29.8 million shares, or 1.66% of free float, the level is elevated relative to where it was in mid-August, but remains low in absolute terms for a large-cap money-center bank. Borrow availability is at the maximum tracked level with over 1.6 billion shares available, and cost to borrow has actually fallen — down 15% on the week to 0.34% — meaning the short build is not creating any meaningful stress in the lending market. The overall positioning picture looks cautious rather than aggressive: hedging has been added, but there's no sign of a concentrated bearish conviction trade.
The analyst picture is similarly mixed. Recent moves have largely gone in one direction — lower targets — with UBS cutting to $142 in early August and Evercore trimming to $135 in mid-July, both maintaining their existing ratings rather than pulling the more bullish reads. The more constructive voices are still present: RBC reiterated Outperform at $150, and BofA raised its target to $176 in early July, keeping its Buy. At $132.54, C trades modestly below the analyst mean target of around $134. The spread between the most constructive ($176 BofA) and most cautious targets reflects genuine disagreement about execution pace, not direction — nearly all analysts still see the stock going higher. The bull case centres on improving efficiency ratios, the capital return programme, and the ongoing transformation under Jane Fraser. Bears point to a long history of operational complexity, credit card segment headwinds, and macro sensitivity through the international franchise. On valuation, the stock trades at roughly 10.8x trailing earnings and 1.08x book — inexpensive by any broad market comparison, though that cheapness has been structural for Citi for years. Factor scores show the stock ranks in the 83rd percentile for EPS surprise and 80th for days-to-cover — both meaningful for a large-cap bank, and both suggesting the underlying earnings quality is more robust than the multiple implies.
Among peers, C held up better than most on the week. KEY fell 3.1% and CFG lost 2.4%, while BAC and JPM slipped roughly half a percent. WFC was the standout, gaining 2.7%. Citi's 0.5% weekly decline puts it in the middle of the group — neither the defensive laggard nor the clear outperformer.
The next hard data point is Q3 earnings on October 13. The most recent comparable print — Q2 results on July 14 — saw the stock fall 4.1% on the day and another 1.5% over the following week. The prior quarter, reported in May, produced a 4.4% gain. The pattern of outsized post-earnings moves, in either direction, makes the current build in put protection look like textbook pre-event positioning rather than a structural shift in sentiment. What to watch between now and mid-October is whether the PCR stabilises around current levels or climbs back toward last week's peak — and whether short interest holds near 30 million shares or fades back toward the mid-August base around 24-25 million.
See the live data behind this article on ORTEX.
Open C on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
